204 related articles for article (PubMed ID: 16563971)
1. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
[TBL] [Abstract][Full Text] [Related]
2. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation.
Fields RC; Bharat A; Steward N; Aloush A; Meyers BF; Trulock EP; Chapman WC; Patterson GA; Mohanakumar T
Transplantation; 2006 Dec; 82(12):1596-601. PubMed ID: 17198242
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
4. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
5. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
Altermann W; Schlaf G; Rothhoff A; Seliger B
Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
[TBL] [Abstract][Full Text] [Related]
6. Value of soluble CD30 in liver transplantation.
Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
Ypsilantis E; Key T; Bradley JA; Morgan CH; Tsui S; Parameshwar J; Taylor CJ
J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
[TBL] [Abstract][Full Text] [Related]
11. CD30, a marker to detect the high-risk kidney transplant recipients.
Spiridon C; Nikaein A; Lerman M; Hunt J; Dickerman R; Mack M
Clin Transplant; 2008; 22(6):765-9. PubMed ID: 19040559
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
13. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
[TBL] [Abstract][Full Text] [Related]
14. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
[TBL] [Abstract][Full Text] [Related]
15. Elevated pretransplantation soluble CD30 is associated with decreased early allograft function after human lung transplantation.
Shah AS; Leffell MS; Lucas D; Zachary AA
Hum Immunol; 2009 Feb; 70(2):101-3. PubMed ID: 19126420
[TBL] [Abstract][Full Text] [Related]
16. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
Azarpira N; Aghdaie MH; Malekpour Z
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
[TBL] [Abstract][Full Text] [Related]
18. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS
Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
